FDA action counts
| Total FDA actions | 1 |
|---|---|
| Warning letters | 1 |
| Recalls | 0 |
| Approval records | 0 |
| Form 483 inspection citations | 0 |
| Most recent action | June 17, 2026 |
Risk pattern analysis
Argus HQ analysis — not an FDA finding
This section is Argus HQ analysis, not an FDA finding. Great India Overseas Pvt. Ltd. dba Silkrute has 1 FDA event on file. A pattern across multiple FDA touchpoints does not by itself establish that any specific product currently poses a risk; it reflects only the frequency of FDA engagement with this company as recorded in Argus HQ's database. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ does not independently verify FDA's underlying findings; this page summarizes what FDA has published and links back to the original FDA source for each event. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures.
Enforcement history
On 2026-06-17, Argus HQ recorded an FDA Warning Letter for Great India Overseas Pvt. Ltd. dba Silkrute, rated "critical" severity in Argus HQ's classification: Great India Overseas Pvt. Ltd. dba Silkrute — Unapproved New Drugs (2026-06-17). Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed.
Frequently asked questions
- Does Argus HQ track new FDA actions for Great India Overseas Pvt. Ltd. dba Silkrute automatically?
- Yes. Argus HQ ingests FDA sources daily, including FDA warning letters, recalls, drug and biologic approvals, and Form 483 inspection observations. When a new FDA action linked to Great India Overseas Pvt. Ltd. dba Silkrute is observed, this page's event count and history update automatically.
- How many FDA actions does Argus HQ track for Great India Overseas Pvt. Ltd. dba Silkrute?
- 1 total: 1 warning letter, 0 recalls, 0 approval records, and 0 Form 483 inspection citations.
- What is the most recent FDA action on file for Great India Overseas Pvt. Ltd. dba Silkrute?
- June 17, 2026. Argus HQ ingests new FDA enforcement records daily.
- Has Great India Overseas Pvt. Ltd. dba Silkrute received FDA warning letters?
- Yes, 1 warning letter on file. See the full history below for each one.
Every FDA action tied to this company, the week it happens.
Free weekly briefing. Real-time alerts on paid plans.
Related enforcement actions
Compare with
- Great India Overseas Pvt. Ltd. dba Silkrute vs Medline Industries, LP
- Great India Overseas Pvt. Ltd. dba Silkrute vs ARROW INTERNATIONAL, LLC
- Great India Overseas Pvt. Ltd. dba Silkrute vs Stryker Sustainability Solutions
- Great India Overseas Pvt. Ltd. dba Silkrute vs Guardian Drug Co. Inc.
- Great India Overseas Pvt. Ltd. dba Silkrute vs B BRAUN MEDICAL INC
Two different companies merged onto this page by mistake? Or a name variant missing? Tell us — corrections@argushq.ai
Compiled by Argus HQ Research from FDA primary sources · Reviewed by Andy Gaber, Founder
Cite this record
Reusing this data in reporting or research? Here’s a ready-made citation.
Argus HQ Research (2026). Great India Overseas Pvt. Ltd. dba Silkrute's Complete FDA Record. Digital Empire LLC. Retrieved from https://argushq.ai/company/great-india-overseas-pvt-ltd-dba-silkrute
"Great India Overseas Pvt. Ltd. dba Silkrute's Complete FDA Record." Argus HQ Research, Digital Empire LLC, 2026, argushq.ai/company/great-india-overseas-pvt-ltd-dba-silkrute.
Argus HQ Research. "Great India Overseas Pvt. Ltd. dba Silkrute's Complete FDA Record." Digital Empire LLC. Accessed July 13, 2026. https://argushq.ai/company/great-india-overseas-pvt-ltd-dba-silkrute.
@misc{argushq_argushq_ai_company_great_india_overseas_pvt_ltd_dba_silkrute_2026,
title = {Great India Overseas Pvt. Ltd. dba Silkrute's Complete FDA Record},
author = {{Argus HQ Research}},
year = {2026},
publisher = {Digital Empire LLC},
url = {https://argushq.ai/company/great-india-overseas-pvt-ltd-dba-silkrute},
note = {Accessed: July 13, 2026}
}Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗